乙型肝炎表面抗原
医学
中止
乙型肝炎
HBeAg
内科学
胃肠病学
算法
免疫学
乙型肝炎病毒
计算机科学
病毒
作者
Simon J. Hume,Danny K. Wong,Man‐Fung Yuen,K. Jackson,Sara Bonanzinga,Sara Vogrin,Samuel Hall,Gareth Burns,Paul Desmond,Vijaya Sundararajan,Dilip Ratnam,Miriam Levy,John Lubel,Amanda Nicoll,Simone I. Strasser,William Sievert,Meng Ngu,Marie Sinclair,Christopher S. Meredith,Gail Matthews
摘要
Accurate biomarkers to predict outcomes following discontinuation of nucleos(t)ide analogue (NA) therapy are needed. We evaluated serum hepatitis B core-related antigen (HBcrAg) level as a biomarker for predicting outcomes after NA discontinuation.
科研通智能强力驱动
Strongly Powered by AbleSci AI